Press Releases

Recent & Archived News

September 16, 2019

Bayer Names Daniella Foster New Head of Public Affairs and Sustainability for Consumer Health Division

Bayer today announced Daniella Foster as the new Head of Public Affairs and Sustainability for the Consumer Health Division, effective September 16. In her new role, Daniella will be responsible...

Learn more
September 12, 2019

Actress Lucy Hale and Bayer Launch #WhyIUD Campaign to Educate Women About IUDs

Actress Lucy Hale is partnering with Bayer, a longstanding leader in women's healthcare, to launch #WhyIUD to help more women get the facts about intrauterine devices (IUDs) so they can make...

Learn more
September 11, 2019

Bayer introduces next generation CT technology, the MEDRAD® Stellant FLEX CT Injection System

Bayer announced today the introduction of the MEDRAD® Stellant FLEX Computed Tomography (CT) Injection System. Stellant FLEX offers the latest CT injection technology from Bayer with a...

Learn more
September 10, 2019

Bayer Consumer Health Products Among OTCs Most Recommended by Pharmacists: Survey

Each year, U.S. News & World Report collaborates with Pharmacy Times to ask thousands of pharmacists: which over-the-counter (OTC) products do you recommend the most? The list of top...

Learn more
September 04, 2019

Bayer Awards $500,000 Grant To The St. Louis Magic House For New STEM Interactive Children's Exhibit

Bayer has awarded The Magic House® St. Louis Children's Museum a $500,000 grant to create the Bayer STEM Pathway, a hands-on, interactive exhibit that will be designed to spark a life-long...

Learn more
September 03, 2019

Bayer appoints Marianne De Backer Head of Pharmaceuticals Business Development & Licensing and Member of Executive Committee

Bayer today announced Marianne De Backer PhD as the new Head of Business Development & Licensing of its Pharmaceuticals Division. She will report to Stefan Oelrich, Member of the Board of...

Learn more
August 27, 2019

Bayer Invests in Future of Agriculture Through Multi-Year Commitment to 4-H and FFA

As thousands of farmers gather at the annual Farm Progress Show, Bayer announced a multi-year, multi-million-dollar commitment to 4-H and the National FFA Organization to develop future leaders in...

Learn more
August 13, 2019

JIVI® (antihemophilic factor [recombinant] PEGylated-aucl) Pharmacokinetic Profile Compared to Eloctate® Showed Improved Characteristics in PK Study of Extended Half-life Recombinant FVIII Therapies

A head-to-head study directly comparing the pharmacokinetic (PK) profiles of two extended half-life (EHL) recombinant factor VIII (FVIII) therapies demonstrated improved PK characteristics for...

Learn more
August 08, 2019

Bayer acquires BlueRock Therapeutics to build leading position in cell therapy

Bayer AG and BlueRock Therapeutics today announced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology company focused on...

Learn more
August 06, 2019

Bayer Awards $1.5 Million Grant To BioSTL To Support Organization's Headquarters And Program Expansion In St. Louis' Emerging Technology District

Bayer has awarded BioSTL, a St. Louis-based non-profit which advances and promotes the region's growing bioscience, innovation and technology community, a $1.5 million grant to support its new...

Learn more

 

Want even more Bayer news?

Check out our Social Media & Blogs.